X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (16834) 16834
Book Review (4160) 4160
Publication (957) 957
Newsletter (743) 743
Book Chapter (156) 156
Book / eBook (109) 109
Newspaper Article (67) 67
Conference Proceeding (56) 56
Magazine Article (49) 49
Dissertation (20) 20
Trade Publication Article (11) 11
Reference (8) 8
Data Set (2) 2
Transcript (2) 2
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (13863) 13863
humans (12503) 12503
male (7721) 7721
female (7247) 7247
diabetes (6931) 6931
middle aged (5803) 5803
risk factors (4498) 4498
endocrinology & metabolism (4354) 4354
aged (4184) 4184
adult (4159) 4159
mortality (3558) 3558
diabetics (3186) 3186
type 2 diabetes (2959) 2959
diabetes mellitus (2953) 2953
diabetic nephropathies (2780) 2780
diabetic nephropathy (2596) 2596
animals (2567) 2567
mellitus (2395) 2395
diabetes mellitus, type 2 - complications (2388) 2388
nephropathy (2324) 2324
hypertension (2304) 2304
research (2282) 2282
urology & nephrology (2175) 2175
care and treatment (2080) 2080
analysis (1881) 1881
kidney diseases (1837) 1837
health aspects (1800) 1800
complications (1752) 1752
risk (1723) 1723
prevalence (1683) 1683
blood pressure (1656) 1656
oxidative stress (1546) 1546
disease (1535) 1535
medicine & public health (1532) 1532
glucose (1456) 1456
cardiovascular disease (1420) 1420
diabetic retinopathy (1398) 1398
diabetic nephropathies - physiopathology (1347) 1347
medical research (1344) 1344
abridged index medicus (1332) 1332
microalbuminuria (1303) 1303
risk-factors (1264) 1264
internal medicine (1256) 1256
diabetes mellitus, type 1 - complications (1253) 1253
medicine, general & internal (1253) 1253
type 1 diabetes (1225) 1225
albuminuria (1220) 1220
complications and side effects (1213) 1213
chronic kidney failure (1178) 1178
development and progression (1170) 1170
disease progression (1167) 1167
treatment outcome (1141) 1141
insulin (1135) 1135
diabetic-nephropathy (1132) 1132
medicine, experimental (1128) 1128
hyperglycemia (1110) 1110
glomerular filtration rate (1098) 1098
follow-up studies (1076) 1076
diabetic nephropathies - epidemiology (1072) 1072
studies (1072) 1072
rats (1061) 1061
nephrology (1059) 1059
prognosis (1055) 1055
cardiovascular-disease (1047) 1047
diabetes mellitus, type 2 - blood (1040) 1040
adolescent (1034) 1034
time factors (1032) 1032
diabetes mellitus, type 2 - physiopathology (1031) 1031
blood-pressure (999) 999
diabetic nephropathies - complications (994) 994
progression (985) 985
inflammation (982) 982
medicine (973) 973
diabetic nephropathies - therapy (972) 972
diabetes mellitus, type 2 - drug therapy (969) 969
proteinuria (958) 958
aged, 80 and over (955) 955
blood glucose - metabolism (950) 950
retrospective studies (940) 940
pharmacology & pharmacy (936) 936
chronic kidney-disease (935) 935
diabetic nephropathies - etiology (929) 929
diabetic nephropathies - drug therapy (923) 923
cross-sectional studies (919) 919
prospective studies (912) 912
cardiovascular diseases (901) 901
association (885) 885
diabetic nephropathies - mortality (882) 882
hypoglycemic agents - therapeutic use (870) 870
research article (863) 863
cohort studies (860) 860
diabetes therapy (848) 848
atherosclerosis (847) 847
chronic kidney disease (847) 847
mice (845) 845
diagnosis (843) 843
rodents (842) 842
patients (825) 825
medicine, research & experimental (820) 820
diabetic nephropathies - blood (814) 814
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (91) 91
Collection Dvlpm't (Acquisitions) - Vendor file (11) 11
Providence Healthcare - Stacks (6) 6
Online Resources - Online (5) 5
Collection Dvlpm't (Acquisitions) - Closed Orders (4) 4
Scarborough Hospital - Birchmount (3) 3
Baycrest Hospital - Stacks (2) 2
Credit Valley Hospital - Stacks (2) 2
Toronto East General Hospital - Stacks (2) 2
Credit Valley Hospital - May be requested in 6-10 wks (1) 1
Humber River Regional Hospital - Finch Stacks (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Markham Stouffville Hospital - Stacks (1) 1
Providence Healthcare - Reference (1) 1
Scarborough Hospital - General (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
Trillium Health Centre - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (17463) 17463
German (176) 176
Spanish (84) 84
French (69) 69
Japanese (27) 27
Korean (23) 23
Polish (19) 19
Portuguese (18) 18
Italian (15) 15
Czech (14) 14
Russian (11) 11
Danish (7) 7
Swedish (7) 7
Hungarian (6) 6
Chinese (5) 5
Croatian (5) 5
Turkish (5) 5
Slovak (4) 4
Romanian (3) 3
Dutch (2) 2
Serbian (2) 2
Bulgarian (1) 1
Finnish (1) 1
Hebrew (1) 1
Persian (1) 1
Romansh (1) 1
Slovenian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2013, Volume 369, Issue 20, pp. 1892 - 1903
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2017, Volume 377, Issue 9, pp. 839 - 848
In a randomized, controlled trial, liraglutide (a glucagon-like peptide 1 receptor agonist) or placebo was added to usual care in patients with type 2... 
MORTALITY | MEDICINE, GENERAL & INTERNAL | CARDIOVASCULAR OUTCOMES | ALBUMINURIA | INTENSIVE GLUCOSE CONTROL | KIDNEY-FUNCTION | DISEASE | RISK | DEATH | NEPHROPATHY | Hypoglycemic Agents - therapeutic use | Glomerular Filtration Rate | Double-Blind Method | Follow-Up Studies | Humans | Middle Aged | Diabetic Nephropathies - drug therapy | Male | Albuminuria - prevention & control | Acute Kidney Injury - prevention & control | Diabetic Nephropathies - mortality | Kidney Failure, Chronic - prevention & control | Glucagon-Like Peptide 1 - agonists | Liraglutide - adverse effects | Liraglutide - therapeutic use | Intention to Treat Analysis | Creatinine - blood | Female | Aged | Diabetes Mellitus, Type 2 - drug therapy | Diabetic Nephropathies - prevention & control | Hypoglycemic Agents - adverse effects | Type 2 diabetes | Care and treatment | Usage | Analysis | Diabetic nephropathies | Outcome and process assessment (Health Care) | Research | Liraglutide | Myocardial infarction | Creatinine | Cerebral infarction | End-stage renal disease | Stroke | Glucagon | Diabetes mellitus | Patients | Risk factors | Clinical outcomes | Glomerular filtration rate | Death | Diabetes | Kidney diseases | Cardiovascular diseases | Drug therapy | Glucagon-like peptide 1 | Long-term effects | Kidney transplantation | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Journal of the American Society of Nephrology, ISSN 1046-6673, 01/2013, Volume 24, Issue 2, pp. 302 - 308
Type 2 diabetes associates with increased risk of mortality, but how kidney disease contributes to this mortality risk among individuals with type 2 diabetes... 
ALL-CAUSE MORTALITY | GLOMERULAR-FILTRATION-RATE | GENERAL-POPULATION | ASSOCIATIONS | UROLOGY & NEPHROLOGY | PROTEINURIA | HIGHER ALBUMINURIA | RENAL-DISEASE | OUTCOMES